There have been 50 recent insider transactions recorded for Soleno Therapeutics, Inc. (SLNO), including 23 buys and 22 sells. Total insider buying was valued at $21.22M and total insider selling at $129.87M.
Notable insiders with recent activity include Manning Meredith, Huang Michael F., Fulk Jennifer. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — SLNO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-27 |
Manning Meredith |
Chief Commercial Officer |
Informative Sell |
558 |
$31.72 |
$17.7K |
64,507 |
| 2026-03-27 |
Huang Michael F. |
Sr. VP of Clinical Development |
Informative Sell |
488 |
$31.72 |
$15.48K |
39,823 |
| 2026-03-02 |
Fulk Jennifer |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-02 |
Fulk Jennifer |
Chief Financial Officer |
RSU Award |
39,200 |
- |
- |
39,200 |
| 2026-01-21 |
Mackaness James H |
Chief Financial Officer |
RSU Award |
32,800 |
$43.65 |
$1.43M |
32,800 |
| 2026-01-21 |
Anish Bhatnagar |
Chief Executive Officer |
RSU Award |
131,400 |
$43.65 |
$5.74M |
131,400 |
| 2026-01-21 |
Yen Kristen |
See Remarks |
RSU Award |
11,900 |
$43.65 |
$519.44K |
11,900 |
| 2026-01-21 |
Manning Meredith |
Chief Commercial Officer |
RSU Award |
32,800 |
$43.65 |
$1.43M |
32,800 |
| 2026-01-21 |
Hirano Patricia C |
See Remarks |
RSU Award |
11,900 |
$43.65 |
$519.44K |
11,900 |
| 2026-01-21 |
Norrett Kevin |
Chief Business Officer |
RSU Award |
4,000 |
$43.65 |
$174.6K |
4,000 |
| 2026-01-21 |
Joshi Manher |
Chief Development Officer |
RSU Award |
4,700 |
$43.65 |
$205.16K |
4,700 |
| 2026-01-21 |
Huang Michael F. |
Sr. VP of Clinical Development |
RSU Award |
11,900 |
$43.65 |
$519.44K |
11,900 |
| 2025-12-15 |
Mackaness James H |
Chief Financial Officer |
Tax Withholding of RSU |
2,013 |
$49.95 |
$100.55K |
103,163 |
| 2025-12-15 |
Anish Bhatnagar |
Chief Executive Officer |
Gift (Given) |
100,000 |
- |
- |
469,456 |
| 2025-12-15 |
Yen Kristen |
See Remarks |
Tax Withholding of RSU |
904 |
$49.95 |
$45.15K |
27,239 |
| 2025-12-15 |
Manning Meredith |
Chief Commercial Officer |
Tax Withholding of RSU |
1,922 |
$49.95 |
$96K |
43,429 |
| 2025-12-15 |
Hirano Patricia C |
See Remarks |
Tax Withholding of RSU |
904 |
$49.95 |
$45.15K |
12,302 |
| 2025-12-15 |
Huang Michael F. |
Sr. VP of Clinical Development |
Tax Withholding of RSU |
812 |
$49.95 |
$40.56K |
36,005 |
| 2025-11-17 |
Norrett Kevin |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-11-17 |
Norrett Kevin |
Chief Business Officer |
RSU Award |
14,286 |
- |
- |
14,286 |
| 2025-11-10 |
Joshi Manher |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-11-10 |
Joshi Manher |
Chief Development Officer |
RSU Award |
16,071 |
- |
- |
16,071 |
| 2025-10-13 |
Hahn Mark W |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-10-13 |
Hahn Mark W |
Director |
RSU Award |
10,046 |
- |
- |
10,046 |
| 2025-07-01 |
Hirano Patricia C |
See Remarks |
Informative Sell |
3,830 |
$82.76 |
$316.97K |
13,206 |
| 2025-06-24 |
Hirano Patricia C |
See Remarks |
Option Exercise (Sell) |
266 |
$44.25 |
$11.77K |
- |
| 2025-06-05 |
Harris William G |
Director |
RSU Award |
3,991 |
- |
- |
19,392 |
| 2025-06-05 |
Pauls Matthew |
Director |
RSU Award |
3,991 |
- |
- |
10,491 |
| 2025-06-05 |
Bir Dawn Carter |
Director |
RSU Award |
3,991 |
- |
- |
16,991 |
| 2025-06-05 |
Volck Birgitte |
Director |
RSU Award |
3,991 |
- |
- |
17,536 |
| 2025-06-05 |
Sinclair Andrew |
Director |
RSU Award |
3,991 |
- |
- |
10,491 |
| 2025-04-01 |
Hirano Patricia C |
See Remarks |
Informative Sell |
3,782 |
$70.11 |
$265.16K |
27,036 |
| 2025-03-28 |
Vivo Opportunity, Llc |
10 Percent Owner |
Informative Sell |
333,557 |
$70.60 |
$23.55M |
4,458,294 |
| 2025-03-28 |
Pauls Matthew |
Director |
Informative Sell |
5,937 |
$71.55 |
$424.8K |
6,500 |
| 2025-03-28 |
Hirano Patricia C |
See Remarks |
Option Exercise (Sell) |
2,691 |
$33.60 |
$90.42K |
18,842 |
| 2025-03-27 |
Vivo Opportunity, Llc |
10 Percent Owner |
Informative Sell |
1,100,000 |
$67.80 |
$74.58M |
4,791,851 |
| 2025-03-27 |
Mackaness James H |
Chief Financial Officer |
Option Exercise (Sell) |
5,000 |
$2.60 |
$12.98K |
- |
| 2025-03-27 |
Anish Bhatnagar |
Chief Executive Officer |
Option Exercise (Sell) |
16,666 |
$25.05 |
$417.48K |
- |
| 2025-03-27 |
Yen Kristen |
See Remarks |
Option Exercise (Sell) |
4,888 |
$5.10 |
$24.93K |
2,445 |
| 2025-03-27 |
Manning Meredith |
Chief Commercial Officer |
Informative Sell |
37,000 |
$67.04 |
$2.48M |
45,351 |
| 2025-03-27 |
Hirano Patricia C |
See Remarks |
Option Exercise (Sell) |
6,000 |
$24.00 |
$144K |
- |
| 2025-03-27 |
Huang Michael F. |
Sr. VP of Clinical Development |
Informative Sell |
10,000 |
$70.03 |
$700.33K |
36,817 |
| 2025-03-26 |
Vivo Opportunity, Llc |
10 Percent Owner |
Informative Sell |
400,000 |
$65.80 |
$26.32M |
5,891,851 |
| 2025-01-21 |
Mackaness James H |
Chief Financial Officer |
RSU Award |
31,000 |
$49.17 |
$1.52M |
31,000 |
| 2025-01-21 |
Anish Bhatnagar |
Chief Executive Officer |
RSU Award |
115,600 |
$49.17 |
$5.68M |
115,600 |
| 2025-01-21 |
Yen Kristen |
See Remarks |
RSU Award |
13,800 |
$49.17 |
$678.55K |
13,800 |
| 2025-01-21 |
Manning Meredith |
Chief Commercial Officer |
RSU Award |
29,200 |
$49.17 |
$1.44M |
29,200 |
| 2025-01-21 |
Hirano Patricia C |
See Remarks |
RSU Award |
13,800 |
$49.17 |
$678.55K |
13,800 |
| 2025-01-21 |
Huang Michael F. |
Sr. VP of Clinical Development |
RSU Award |
13,800 |
$49.17 |
$678.55K |
13,800 |
| 2025-01-03 |
Mackaness James H |
Chief Financial Officer |
Informative Sell |
3,791 |
$46.18 |
$175.05K |
111,298 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
